A ProspectiVe RegIstry to Cure Triple-Negative Breast Cancer in Patients with Early-Stage OR NewlY Diagnosed Metastatic Disease: VICTORY (DF/HCC 18-617)

Study Details

This is a prospective, multi-institutional registry of patients with newly diagnosed Triple Negative Breast Cancer (Stage I-IV). Our goal is to collect clinical data, tissue samples, blood samples, stool samples, and patient-reported data over the course of a patient’s treatment and follow-up. We aim to provide clinicians and scientists a comprehensive platform of biospecimens and data to ultimately promote and facilitate innovative future research.

ClinicalTrials.gov NCT number
NCT Not Applicable

Principal Investigators

  • Steve Lo, MD
Sponsor(s)
Dana-Farber Cancer Institute
Contact
Mary Miller, LPN at 203-358-8879
or officeofresearch@stamhealth.org

Location

  • Bennett Cancer Center
    One Hospital Plaza
    Stamford, CT 06902
    Main: 203-276-2695
There is no panel matching the key "Cookie-Notification"